{"grounding": "Inflammation and its timely resolution are critical to ensure effective host defense and appropriate tissue repair after injury and or infection. Chronic, unresolved inflammation typifies many prevalent pathologies. The key mediators that initiate and drive the inflammatory response are well defined and targeted by conventional anti-inflammatory therapeutics. More recently, there is a growing appreciation that specific mediators, including arachidonate-derived lipoxins, are generated in self-limiting inflammatory responses to promote the resolution of inflammation and endogenous repair mechanisms without compromising host defense. We discuss the proresolving biological actions of lipoxins and recent efforts to harness their therapeutic potential through the development of novel, potent lipoxin mimetics generated via efficient, modular stereoselective synthetic pathways. We consider the evidence that lipoxin mimetics may have applications in limiting inflammation and reversing fibrosis and the underlying mechanisms.", "generated_text": "Lipoxins, endogenous pro-resolving mediators, play a crucial role in the resolution of inflammation. This review explores the potential of lipoxin mimetics as therapeutic agents for inflammatory disorders and fibrosis. We focus on two novel lipoxin analogs, AT-01-KG and AT-02-CT, which demonstrate enhanced stability and potency compared to natural lipoxins. These mimetics exhibit promising anti-inflammatory and anti-fibrotic properties in various preclinical models, including respiratory, cardiovascular, and renal diseases. By promoting the resolution of inflammation and tissue repair, lipoxin mimetics offer a novel approach to treating chronic inflammatory conditions. We discuss the mechanisms of action, pharmacokinetics, and safety profiles of these compounds, as well as their potential advantages over traditional anti-inflammatory therapies. The development of lipoxin mimetics represents a significant advancement in the field of inflammation resolution and may lead to more effective treatments for a wide range of inflammatory disorders.", "label": 1}